Atlas Trials

Complicated Intra-abdominal Infection

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Complicated Intra-abdominal Infection

RecordFirmDate
Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection (NCT04927312)Pfizer2021-10-01
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. (NCT03329092)Pfizer2018-04-05
MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035) (NCT03217136)Merck Sharp & Dohme LLC2018-04-03
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017) (NCT03293485)Merck Sharp & Dohme LLC2017-10-04
Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013) (NCT02739997)Merck Sharp & Dohme LLC2016-04-08
Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections (NCT01726023)Pfizer2013-01-01
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens (NCT01644643)Pfizer2013-01-01
Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections (NCT01499290)Pfizer2012-03-01
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections (NCT01445678)Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2011-12-23
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia (NCT00914888)Wyeth is now a wholly owned subsidiary of Pfizer2011-01-01
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia (NCT01602874)Pfizer2011-01-01
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections (NCT01265784)Tetraphase Pharmaceuticals, Inc2011-01-01
Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections (NCT01147640)Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2010-06-25
Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal Infections (NCT00929643)Wyeth is now a wholly owned subsidiary of Pfizer2008-11-01

Track Complicated Intra-abdominal Infection automatically

Every clearance here is in the API, with alerts when new ones post.